(UPDATE) Niraparib
Mirvetuximab Soravtasine-gynx (Elahere)
Olaparib
Bevacizumab
Rivkin Center for Ovarian Cancer
NCCN Guidelines for Patients®
ASCO: COVID-19 Medical Resources
Ovarian Cancer Research Fund Alliance